技术与方法 |
|
|
|
|
基因修饰人多能干细胞的高效单克隆建系方法 |
钱昱1,丁晓雨2,刘志强2,*(),袁增强2,*() |
1 南华大学研究生院 衡阳 421001 2 军事科学院军事医学研究院军事认知与脑科学研究所 北京 100850 |
|
An Efficient Monoclonal Establishment Method of Genetically Modified Human Pluripotent Stem Cells |
QIAN Yu1,DING Xiao-yu2,LIU Zhi-qiang2,*(),YUAN Zeng-qiang2,*() |
1 College of Graduate Studies, University of South China, Hengyang 421001, China 2 Institute of Military Cognition and Brain Sciences, Beijing 100850, China |
引用本文:
钱昱,丁晓雨,刘志强,袁增强. 基因修饰人多能干细胞的高效单克隆建系方法[J]. 中国生物工程杂志, 2021, 41(8): 33-41.
QIAN Yu,DING Xiao-yu,LIU Zhi-qiang,YUAN Zeng-qiang. An Efficient Monoclonal Establishment Method of Genetically Modified Human Pluripotent Stem Cells. China Biotechnology, 2021, 41(8): 33-41.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2103012
或
https://manu60.magtech.com.cn/biotech/CN/Y2021/V41/I8/33
|
[1] |
Shahror R A, Wu C C, Chiang Y H, et al. Genetically modified mesenchymal stem cells: the next generation of stem cell-based therapy for TBI. International Journal of Molecular Sciences, 2020, 21(11):4051.
doi: 10.3390/ijms21114051
|
[2] |
Nedelec S, Onteniente B, Peschanski M, et al. Genetically-modified human pluripotent stem cells: new hopes for the understanding and the treatment of neurological diseases? Current Gene Therapy, 2013, 13(2):111-119.
doi: 10.2174/1566523211313020005
|
[3] |
Nowakowski A, Andrzejewska A, Janowski M, et al. Genetic engineering of stem cells for enhanced therapy. Acta Neurobiologiae Experimentalis, 2013, 73(1):1-18.
pmid: 23595280
|
[4] |
Liew A, André F M, Lesueur L L, et al. Robust, efficient, and practical electrogene transfer method for human mesenchymal stem cells using square electric pulses. Human Gene Therapy Methods, 2013, 24(5):289-297.
doi: 10.1089/hgtb.2012.159
|
[5] |
Picanco-Castro V, de Sousa Russo-Carbolante E M, Tadeu Covas D. Advances in lentiviral vectors: a patent review. Recent Patents on DNA & Gene Sequences, 2012, 6(2):82-90.
|
[6] |
Dwivedi P P, Anderson P J, Powell B C. Development of an efficient, non-viral transfection method for studying gene function and bone growth in human primary cranial suture mesenchymal cells reveals that the cells respond to BMP2 and BMP3. BMC Biotechnology, 2012, 12:45.
doi: 10.1186/1472-6750-12-45
pmid: 22857382
|
[7] |
Bokhoven M, Stephen S L, Knight S, et al. Insertional gene activation by lentiviral and gammaretroviral vectors. Journal of Virology, 2009, 83(1):283-294.
doi: 10.1128/JVI.01865-08
pmid: 18945765
|
[8] |
Kobayashi N, Rivas-Carrillo J D, Soto-Gutierrez A, et al. Gene delivery to embryonic stem cells. Birth Defects Research Part C,Embryo Today, 2005, 75(1):10-18.
doi: 10.1002/(ISSN)1542-9768
|
[9] |
Zhang Q Y, Li X D, Liu S Q, et al. Development of a stable Japanese encephalitis virus replicon cell line for antiviral screening. Archives of Virology, 2017, 162(11):3417-3423.
doi: 10.1007/s00705-017-3508-9
|
[10] |
Givan A L. Flow cytometry: an introduction. Methods in Molecular Biology (Clifton, N J), 2011, 699:1-29.
|
[11] |
Kim K, Min S, Kim D, et al. A rho kinase (ROCK) inhibitor, Y-27632, inhibits the dissociation-induced cell death of salivary gland stem cells. Molecules, 2021, 26(9):2658.
doi: 10.3390/molecules26092658
|
[12] |
Rezania A, Bruin J E, Arora P, et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nature Biotechnology, 2014, 32(11):1121-1133.
doi: 10.1038/nbt.3033
|
[13] |
Ungrin M D, Joshi C, Nica A, et al. Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One, 2008, 3(2):e1565.
|
[14] |
Kurosawa H. Application of Rho-associated protein kinase (ROCK) inhibitor to human pluripotent stem cells. Journal of Bioscience and Bioengineering, 2012, 114(6):577-581.
doi: 10.1016/j.jbiosc.2012.07.013
pmid: 22898436
|
[15] |
Narumiya S, Thumkeo D. Rho signaling research: history, current status and future directions. FEBS Letters, 2018, 592(11):1763-1776.
doi: 10.1002/1873-3468.13087
pmid: 29749605
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|